What is the address of LVX Medica?

The registered office of LVX Medica is located at Chaussée de Beaumont(BLW) 76, 6440 Froidchapelle.

Is LVX Medica still active?

Yes. According to the CBE (30 October 2026) LVX Medica is active, legal situation “Normale toestand”, started on 8 September 2023.

Is LVX Medica registered on Peppol?

Yes, LVX Medica is registered on the Peppol network with ID 0208:0805627263.

What is the enterprise number of LVX Medica?

The enterprise number of LVX Medica is BE0805627263.

When was LVX Medica founded?

LVX Medica was founded on 8 September 2023.

Who are the directors of LVX Medica?

According to the 2025 annual accounts, the directors of LVX Medica are: Louis VANDERSCHUEREN.

Is LVX Medica a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 September 2023; 2 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did LVX Medica make in 2025?

LVX Medica posted a profit after taxes of € 179,101 in financial year 2025.

What is the revenue of LVX Medica?

As a small company, LVX Medica is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 260,619.

LVX Medica (Private Limited) - Froidchapelle

Dossier LVX Medica, printed on 30 October 2026 from databakkes.be/en/0805627263/lvx-medica. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LVX Medica from Froidchapelle, company number BE0805627263, closed financial year 2025 with a result of € 179,101 after tax. For that financial year LVX Medica recorded a gross margin of € 260,619 and equity of € 254,829. Compared with financial year 2024, the result moved from € 72,728 to € 179,101. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 24, 2026.

What it is worth Growing

€ 254,829

▲ 237% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 179,101

▲ 146% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 151,027

▲ 170% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 251,829.

People and assets in 2025

Vehicles and equipment

€ 10,939

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 28

▼ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 28,802

▲ 296% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2024	2025	Change 2024 → 2025
Gross margin	€ 106,268 Gross margin 2024: € 106,268 First fiscal year in the series	€ 260,619 Gross margin 2025: € 260,619 ▲ 145% vs 2024 (€ 106,268) Favourable step	▲ 145%
Profit after taxes	€ 72,728 Profit after taxes 2024: € 72,728 First fiscal year in the series	€ 179,101 Profit after taxes 2025: € 179,101 ▲ 146% vs 2024 (€ 72,728) Favourable step	▲ 146%
Equity	€ 75,728 Equity 2024: € 75,728 First fiscal year in the series	€ 254,829 Equity 2025: € 254,829 ▲ 237% vs 2024 (€ 75,728) Favourable step	▲ 237%
Total debts	€ 7,509 Total debts 2024: € 7,509 First fiscal year in the series	€ 28,830 Total debts 2025: € 28,830 ▲ 284% vs 2024 (€ 7,509) Unfavourable step	▲ 284%
Cash	€ 55,847 Cash 2024: € 55,847 First fiscal year in the series	€ 151,027 Cash 2025: € 151,027 ▲ 170% vs 2024 (€ 55,847) Favourable step	▲ 170%
Retained profit	€ 72,728 Retained profit 2024: € 72,728 First fiscal year in the series	€ 251,829 Retained profit 2025: € 251,829 ▲ 246% vs 2024 (€ 72,728) Favourable step	▲ 246%
Balance sheet total	€ 83,238 Balance sheet total 2024: € 83,238 First fiscal year in the series	€ 283,659 Balance sheet total 2025: € 283,659 ▲ 241% vs 2024 (€ 83,238) Unchanged	▲ 241%

Key figures of LVX Medica, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to LVX Medica?

What happened at LVX Medica in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 24, 2026 New annual accounts for financial year 2025: profit of € 179,101 (▲ 146% vs 2024). Source: NBB ↗
Oct 1, 2023 New establishment in Froidchapelle. KBO
Sep 8, 2023 Start of the company according to the CBE. KBO

In short

From € 72,728 profit in 2024 to € 179,101 profit in 2025.

Paid € 108,893 in corporate taxes since 2024.

Best year ever: 2025, with € 179,101 profit.

Original PDFs at the National Bank ↗

Management

Louis VANDERSCHUEREN

LVX Medica

Behind LVX Medica is Louis VANDERSCHUEREN.

Directors

According to the 2025 annual accounts

Louis VANDERSCHUEREN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Beaumont(BLW) 76

6440 Froidchapelle

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

IMOVDS

€ 70,424 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0805.627.263
VAT number: BE 0805.627.263
Registered office: Chaussée de Beaumont(BLW) 76, 6440 Froidchapelle
Names & denominations: LVX Medica
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 September 2023
Peppol: Active · Active since 16 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗